Recent developments and emerging trends of mass spectrometry for herbal ingredients analysis

Recent developments and emerging trends of mass spectrometry for herbal ingredients analysis

Accepted Manuscript Recent developments and emerging trends of mass spectrometry for herbal ingredients analysis Aihua Zhang, Hui Sun, Guangli Yan, Xi...

765KB Sizes 0 Downloads 84 Views

Accepted Manuscript Recent developments and emerging trends of mass spectrometry for herbal ingredients analysis Aihua Zhang, Hui Sun, Guangli Yan, Xijun Wang PII:

S0165-9936(17)30111-5

DOI:

10.1016/j.trac.2017.07.007

Reference:

TRAC 14955

To appear in:

Trends in Analytical Chemistry

Received Date: 27 March 2017 Revised Date:

1 July 2017

Accepted Date: 10 July 2017

Please cite this article as: A. Zhang, H. Sun, G. Yan, X. Wang, Recent developments and emerging trends of mass spectrometry for herbal ingredients analysis, Trends in Analytical Chemistry (2017), doi: 10.1016/j.trac.2017.07.007. This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

ACCEPTED MANUSCRIPT

Recent developments and emerging trends of mass spectrometry for herbal ingredients analysis

RI PT

Aihua Zhang, Hui Sun, Guangli Yan, Xijun Wang* Sino-America Chinmedomics Technology Collaboration Center, National TCM Key Laboratory of Serum Pharmacochemistry, Chinmedomics Research Center of TCM State Administration, Metabolomics Laboratory, Department of Pharmaceutical Analysis, Heilongjiang University of Chinese Medicine, Heping Road 24, Harbin

AC C

EP

TE D

M AN U

SC

150040, China.

Address correspondence to: Prof. Xijun Wang

Sino-America Chinmedomics Technology Collaboration Center, National TCM Key Laboratory of Serum Pharmacochemistry, Chinmedomics Research Center of TCM State Administration, Metabolomics Laboratory, Department of Pharmaceutical Analysis, Heilongjiang University of Chinese Medicine, Heping Road 24, Harbin 150040, China. Email: [email protected]

1

ACCEPTED MANUSCRIPT

Abstract:

Herbal preparation has recently increased health awareness and its efficacy is brought about by the multi-constituents. Therefore, the application of mass spectrometry (MS) in herbal preparation has been dramatically growing due to the improved detection capabilities. It offered high sensitivity, high-throughput and selectivity, has better accuracy, and can be utilized to quantitative, qualitative and imaging. High-throughput screening method integrated with MS platform is an excellent tool to analyse the multi-components of herbal preparation in the post-genomic era. For

RI PT

providing an up-to-date overview of MS application on the HM-derived compounds, the papers published in the latest years involving quantitative and qualitative analysis of chemical constituents and MS platform integrated with high-throughput screening method are summarized in this review. Examples of the application of MS in the HM

SC

sciences focusing on chemical analysis are highlighted, and new developments and future prospects are also highlighted. Keywords:

AC C

EP

TE D

M AN U

Mass spectrometry; herbal preparation; chemical constituents; natural products; identification

2

ACCEPTED MANUSCRIPT

1. Introduction

The discovery of natural product artemisinin from the herb Artemisia annua that brought breakthroughs in the therapy of tropical parasitic diseases was awarded for Youyou Tu that received the Nobel Prize for Medicine 2015 [1]. It demonstrates the importance of herbal medicine (HM)-derived drugs. Today, increasing studies have focused on natural compounds extracted from herbal preparation [2,3]. The bioactive compounds from herbal medicine have continued to play an important role in drug discovery, and more than 50% drugs used in pharmacopoeia are derived

RI PT

from herbs [4-6]. The most well-known examples include taxanes (docetaxel, paclitaxel), vinca alkaloids (vinorelbine, vindesine, vinblastine, vincristine), podophyllotoxin and its derivative (teniposide and etoposide), anthracyclines (idarubicin, epirubicin, daunorubicin, doxorubicin), camptothecin and its derivatives (irinothecan and topothecan),

SC

and others [7-12]. Based on the therapeutic effects, thousands of herbal preparations have been practiced for many millennia and thus been widely accepted by Asian communities. There is a higher possibility of discovering a bioactive conpound from HM based on their therapeutic effects, rather than from other natural sources via random

M AN U

screening.

Currently, more and more attention has been focused on drug discovery from natural compounds of HM [13]. The HM are complex, and their components may act on multiple targets. Various techniques have allowed researchers to acquire more insights into these components are lacking. Hence, fast, sensitive and effective analytical tools and methods are needed to acquire a better understanding of the phytoconstituents of HM and to enhance its quality

TE D

control. Fortunately, mass spectrometry (MS) can provide us with useful structural information for chemical constituents derived from HM [14-16]. MS can capture the candidate molecules, facilitate their identification of novel chemical structures. Recently, MS has been recognized as yielding huge potential for high-throughput discovery of

EP

new lead compounds from HM [17]. The effectiveness of the MS-based methods was demonstrated for the discovery of bioactive compounds and elucidation of the action mechanisms of herbal preparation [18-21]. These studies

AC C

suggest that the MS approach provides a new research paradigm for translating HM from experience-based medicine to an evidence-based medicine. Many scientists have attempted to develop an appropriate approach rely upon MS for the screening effective compounds from HM, due to high-throughput MS characteristics [22-27]. In this context, the implementation of the MS platform integrated with high-throughput screening strategies is very essential for quantitative and qualitative analysis of herbal constituents. This critical review covers the use of MS with related techniques and methodologies for phytoconstituents discovery, identification, determination, and also highlights high-throughput screening method suitable for effective ingredients in medicinal plants illustrated by recent successful cases.

2. Natural products for disease treatment Herbal medicines are widely used for a long period, predominately as over the counter preparations. The main driver 3

for the use of herbal is the unmet needACCEPTED of patients. There MANUSCRIPT is another an impressive revival of seeking new drugs from natural compounds. HM is a valuable source of novel chemical structures and contains multiple active ingredients that have the possibility of be beneficial for disease prevention and treatment [28-32]. Currently, it is the primary form of health care in the developing countries, and also is widely used as a supplement in developed countries. HM is the most widely practiced form of herbalism worldwide and has always contributed extensively towards the development of modern medicine. To discover novel lead compounds, herbal ingredients, single herbs and formula in

RI PT

HM is important areas for disease therapy. Treatment effect of formula in HM that involves multi-targets and multipathways may be superior than that of the single agent targeting a single target [33-36]. The formulas consist of a combination of multi-constituents and have been widely used because of their effects protecting against many

SC

diseases [37,38]. However, due to the extreme complexity of chemical components and potential actions, a comprehensive understanding of HM using conventional phytochemical tools still faces many challenges, which have hindered the process of TCM modernization. To address this, research in this field requires a comprehensive

M AN U

approach to identify active ingredients. Establishing high throughput screening method is indispensable for the purpose. Traditional bioassays are time-consuming and are not able to easily identify the different constituents. Recently, MS is an ideal method to address these challenges and has demonstrated its merits for analyzing the known compounds and elucidation of unknown compounds in HM [39-43]. Recently, a number of studies describing the effective strategies for active constituents in HM have been reported and greatly expedited identification and

TE D

characterization of the phytoconstituents [44-47]. With the progress of MS technology and method, the action mechanisms of HM will be further demonstrated, more and more herbs and formulas will be used as an effective

EP

therapy.

3. Evolving MS platform for HM: determining the need

AC C

In the past decade, there has been growing interests in the usage of HM due to the increasing awareness of people in their health benefits [48]. HM is usually composed of multi-components responsible for their efficacies. Therefore, the systematic identification of the chemical components in HM is important in order to deciphering the action basis of the therapeutic effects. However, due to difficulties of isolation and preparation, conventional phytochemical tool is unrealistic and unpractical to studies on the high polarity, non-chromophores and low abundance compounds. It is a time-consuming and labor-intensive process, because of chemical diversity of HM. So, there is imperative to develop a sensitive and feasible method for qualitative analysis of the phytoconstituents in HM. Numerous efforts were made to identify the effective constituents from HM [49-52]. Various analytical techniques are used in HM which could be divided into two categories: MS and nuclear magnetic resonance (NMR). More attention has been paid to develop the chemical constituents analysis with MS [53-56]. These techniques have led to considerable development in screening phytoconstituents from HM. In addition, high resolution MS could rapidly identify the active compound, tandem MS 4

ACCEPTED MANUSCRIPT may combine the bioactive screening steps as one and providing more useful information for the HM study. Primarily, MS is used to sensitively and specifically detecting known constituents and identifying unknown constituents. MS-based screening assay could provide a powerful and practical approach for rapid screening from HM [57]. The combination of rapid and sensitive analytical tools with MS, the so-called “hyphenated techniques”, can play an increasingly important role in the phytopharmaceuticals. Particularly, these hyphenated techniques is an important tool used for high-throughput screening and rapid identification of compounds from HM [58]. For example,

RI PT

ultra-high pressure liquid chromatography (UPLC) can increase the speed of analysis, improving separation sensitivity, resolution and efficiency, and reduce the solvent consumption, compared to other analytical approaches. Commonly used MS detector types include single quadrupoles, triple quadrupoles, ion traps, orbitraps, time-of-flight

SC

(TOF). Applications of UPLC coupled with different detection tools for determining herbal constituents of HM have been recently reported. For example, Zhang QQ et al. had established a fast UPLC-QTOF/MS method to characterize multiple constituents in Danhong injection [59]. A total of 63 compounds, including 2C-glycosyl quinochalcones, 33

M AN U

phenolic acids, 6 flavonoid O-glycosides, 6 organic acids, 5 amino acids, 4 iridoid glycosides, and 3 nucleosides, were tentatively characterized. Dong P et al. had developed UHLC-QTOF/MS to quickly identify the chemical components and understand the chemical profiles of Zibu Piyin Recipe [60]. A total of 155 compounds in Zibu Piyin Recipe was tentatively identified using the optimized method. Zou D et al. established UPLC- Orbitrap-MS approach

HM prescription [61].

TE D

for systematically screening and characterizing the chemical constituents of Wuzi-Yanzong-Wan which is a classical

4. Mass spectrometry identification in vivo ingredients

EP

Identification of the phytoconstituents in HM preparations is crucial to revealing the therapeutic basis and action mechanism. The traditional practice of isolation, purification, and biological activity screening in vitro is

AC C

time-consuming and poorly efficiency. Identification of the bioactive ingredients from HM by traditional approach remains a challenge. Fortunately, the integration of mass spectrometry based technologies efforts with with integrative approach, has driven the development of a new drug discovery paradigm. It provides highly specific structural information related to ingredient and metabolite identity such as isotope distribution patterns, an ions accurate mass, and characteristic fragment ions used for structural elucidation [62-66]. The compounds absorbed into the blood had chances to bring about bioactivities [67]. However, the concentrations of some compounds after oral administration of HM, are quite low, and therefore increase the complexity of the detection in vivo. In recent years, the scientists have developed a lot of methods to clarify the chemical components for HM, such as serum pharmacochemistry, and fingerprint chromatography [68-70]. In views of this, the screening strategy of plasma pharmacochemistry was proposed and introduced that bioactive components can reveal their therapeutic effects only when they can be discovered in blood with suitable concentrations after administration of 5

MANUSCRIPT herbal preparation [71]. This strategy ACCEPTED is effective and straightforward and has been widely accepted to screen and investigating the bioactive components in HM. Serum pharmacochemistry approach has been used to profile the active constituents by the MS technique [72-76]. This approach is demonstrated to be effective tool for bioactive compound screening and identification in vivo ingredients and reported on some herbal preparations [77-81]. In a study, the plasma pharmacochemistry strategy integrating and MS analysis was used to screening the in vivo components of Daming capsule [82]. Six anthraquinones with fast and high absorption were screened as potentially

HM, providing new insights into the development and research of new drugs.

SC

5. High-throughput MS screening approach

RI PT

active compounds of Daming capsule. It facilitated the identification and screening of functional components from

Complex diseases are serious threats to human health. Recently, the drug discovery approach of “single drug and single target” was found to be limited against complex diseases [83]. New multicomponent drugs development is

M AN U

imperative, and a suitable solution establishment. HM is a sophisticated systems and has been recognized as a renewable resource for the discovery of novel drugs. The rapid screening method offers an efficient way to discover bioactive compounds from HM. To bridge the gap between HM system and modern molecular biology, MS will be considered one of the most helpful tools available. High-throughput MS has become fundamental tool to the development of innovative drug for complex diseases. Utilizing MS, researchers can reveal therapeutic effects

TE D

generated from multi-ingredients, multi-targets of HM, develop innovative drugs. Ling Y et al had establish a rapid and sensitive MS method to rapidly determine the active ingredients in a well-known formula Cong-Ming-Tang for the amnesia treatment [84]. It allowed the identification of 55 compounds

EP

including 4 sucrose esters, 4 xanthone C-glycosides, 15 triterpene saponins, 11 oligosaccharide multi-esters, 2 lignans 15 triterpene acids and 4 phenylpropanoids. Sixteen compounds were unambiguously identified by comparing the MS

AC C

data, and 38 compounds were tentatively characterized from Cong-Ming-Tang. A called screening method by combining MS for mitochondria-targeted bioactive constituents was developed for searching mitochondria-targeted compounds from Scutellariae Radix [85]. Nineteen bioactive compounds were identified by MS, of which 17 were new mitochondria-targeted compounds, and the bioactivity of 9 hit compounds was confirmed using in vitro test. A study using human neuroblastoma SH-SY5Y cells was to screen bioactive compounds of Radix Bupleuri and discover the anti-schizophrenic candidate drugs [86]. The components such as saikosaponin B1, saikosaponin B2, saikosaponin A, saikosaponin D and saikosaponin C were identified and detected by the MS method under the optimized conditions. A study has been undertaken to establish the hyphenated MS method of bioactivity-guided fractionation to identify the bioactive constituents of a well-known formula Xiao Chai Hu Decoction (XCHD) [87]. As a result, 79 compounds including flavonoids, saikosaponins, polysaccharides, licoricesaponins, ginsenosides and gingerols were detected, 69 of them were tentatively characterized. A segmented selected reaction monitoring MS 6

ACCEPTED MANUSCRIPT strategy were established to simultaneously monitoring 63 licorice metabolites in vivo, and obtained the pharmacokinetics profiles of 55 metabolites [88]. In a study, an efficient strategy based on bioassay-guided method with MS technology was established to accurately and rapidly screen active constituents in HM [89]. These results may be significant significance for in-depth understanding of components and drug discovery from medicinal herbs.

6. Application and practices of the combined MS strategy

RI PT

HM has complex chemical compositions, including the alkaloids, flavonoids, terpenoids, saponins and phenolic acids that demonstrated to have potential pharmacological properties [90]. Clarifying which constituents have therapeutic effects is of great importance for understanding their action mechanism. The exploration of chemical constituents

SC

from HM may provide candidates for high-throughput screenings of most promising drug candidates [91]. However, in contrast to the chemical synthetic drugs, compounds from HM are likely to have complex structures which slow down the identification process and contribute to some problems that were related to supply and manufacturing.

M AN U

Conventional approaches are generally inaccurate, not very specific, and lacking sensitivity, meaning that new promising drug candidates present in minor levels can easily be overlooked.

A study presented an integrated strategy that used UHPLC/LTQ-Orbitrap-MS for the rapid characterization and discovery of the bioactive molecules from Uncaria rhynchophylla (UR) [92]. Ultimately, a total of 92 alkaloids (32 alkaloid O-glycosides and 60 free alkaloids) were characterized, 56 of which are potential new alkaloids for UR. A

TE D

new strategy of metabolite discovery and identification was established by HPLC-HRMS technique [93]. This technique was developed to discovering comprehensive metabolites from multiple bioactive constituents. Altogether, 115 metabolites of 5 flavonoid monomers (baohuoside I, epimedin C, icariin, epimedin A, epimedin B) were

EP

discovered and identified in vivo via this new strategy. A combined MS strategy using both phytochemical and biological approaches was used to screen the chemical constituents of Glycyrrhiza uralensis (licorice) [94]. A total of

AC C

122 compounds were identified by MS from the roots and rhizomes of licorice. These constituents were then further screened using enzyme- and cell-based bioassay. The bioactive compounds such as isoprenylated phenolics were found for the first time. In a study, plasma pharmacochemistry method by LC-MS were performed to screen the active components in Daming capsule [82]. These integrated strategies would be powerful tools for combinatorial screening for lead-like drug candidate in discovery and development for HM. A novel methodology based on a dose-dependent targeted knockout (DDTK) technique were used to identify the chemical profiling of licorice [95]. MS incorporated with the DDTK technique were employed to identify the compounds. Among the detected 232 compounds, twenty-seven compounds were unequivocally identified and 165 compounds, including twenty-nine different compounds were tentatively characterized. It opens the door the further identification of compounds from complicated HM. Chinmedomics by integrating serum pharmacochemistry and metabolomics technology has been proposed by Wang XJ et al, was to discover effective constituents of ShenQiWan protecting against kidney-yang 7

ACCEPTED MANUSCRIPT deficiency syndrome [96]. With the serum pharmacochemistry and MS, a total of 56 compounds were tentatively characterized in vivo and 17 potential biomarkers in urine were analyzed via the metabolomics method (Figure 1). Correlation analysis between potential biomarkers in urine and constituents in vivo showed that 28 compounds had a close relationship with therapeutic effects. The combination of proposed novel methods with mass spectrometry techniques provide a powerful tool in the discovery of new and novel bioactive compounds.

RI PT

7. Conclusion and Perspectives

HM has attracted more and more attention since it can exhibit complementary therapeutic effects against diseases. It is urgent to investigate the phytoconstituents, establish the integrated evaluation system and discover the active

SC

constituents in the HM. In recent years, MS was considered as a useful tool for the identification of phytoconstituents. Within the pharmaceutical industry, there has been a tendency to increasing the throughput natural compounds screening. MS application has opened the possibility to provide more data in a time-efficient manner. In this review,

M AN U

we describe how conjunction of MS with related techniques and method could provide us with useful structural information for discovery and exploration of chemical constituents from HM, and also summarise some of the strategies that are drawn up in HM research. In this review, we wanted to introduce an integrated MS platform in qualitative and quantitative analysis of chemical constituents. The use of this method has reiterated the importance of MS in the HM, and numerous studies have demonstrated that utility of MS combined the differential screening

TE D

strategies were established with the aim of identifying phytoconstituents from HM, and it will increase the success rate in the discovery project of natural medicine.

EP

Acknowledgments

This work was supported by grants from the Key Program of Natural Science Foundation of State (Grant No.

AC C

81430093, 81373930, 81673586, 81302905), National Key Subject of Drug Innovation (Grant No. 2015ZX09101043-005, 2015ZX09101043-011), Natural Science Foundation of Heilongjiang Province of China (H2015038), Program for Youth Innovative Talents in Heilongjiang Province of China (UNPYSCT-2015118).

Competing financial interests

The authors declare no competing financial interests.

8

ACCEPTED MANUSCRIPT

References

1. Liu W, Liu Y. Youyou Tu: significance of winning the 2015 Nobel Prize in Physiology or Medicine. Cardiovasc Diagn Ther. 2016;6(1):1-2. 2. Harvey AL, Edrada-Ebel R, Quinn RJ. The re-emergence of natural products for drug discovery in the genomics era. Nat Rev Drug Discov. 2015;14(2):111-29 3. Tu Y. The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine. Nat Med. 2011;17(10):1217-20.

products. Nat Prod Rep. 2016. DOI: 10.1039/c6np00024j.

RI PT

4. Henke MT, Kelleher NL. Modern mass spectrometry for synthetic biology and structure-based discovery of natural

5. Zhang A, Sun H, Wang X. Recent advances in natural products from plants for treatment of liver diseases. Eur J

SC

Med Chem. 2013;63:570-7.

6. Pei T, Zheng C, Huang C, Chen X, Guo Z, Fu Y, Liu J, Wang Y. Systematic understanding the mechanisms of vitiligo pathogenesis and its treatment by Qubaibabuqi formula. J Ethnopharmacol. 2016;190:272-287.

M AN U

7. Sun H, Wu F, Zhang A, Wei W, Han Y, Wang X. Pharmacokinetic study of schisandrin, schisandrol B, schisantherin A, deoxyschisandrin, and schisandrin B in rat plasma after oral administration of Shengmaisan formula by UPLC-MS. J Sep Sci. 2013;36(3):485-91.

8. Pérez-Moreno G, Cantizani J, Sánchez-Carrasco P, Ruiz-Pérez LM, Martín J, El Aouad N, Pérez-Victoria I, Tormo JR, González-Menendez V, González I, de Pedro N, Reyes F, Genilloud O, Vicente F, González-Pacanowska D.

TE D

Discovery of New Compounds Active against Plasmodium falciparum by High Throughput Screening of Microbial Natural Products. PLoS One. 2016;11(1):e0145812.

9. Sun H, Wu F, Zhang A, Wei W, Han Y, Wang X. Profiling and identification of the absorbed constituents and

EP

metabolites of schisandra lignans by ultra-performance liquid chromatography coupled to mass spectrometry. Biomed Chromatogr. 2013;27(11):1511-9.

AC C

10. Wang Y, Liang X, Chen Y, Zhao X. Screening SIRT1 Activators from Medicinal Plants as Bioactive Compounds against Oxidative Damage in Mitochondrial Function. Oxid Med Cell Longev. 2016;2016:4206392 11. Li D, Wang T, Guo Y, Hu Y, Yu B, Qi J. Online screening of nitric oxide scavengers in natural products using high performance liquid chromatography coupled with tandem diode array and fluorescence detection. J Chromatogr A. 2015;1425:106-15.

12. Wang X, Yang B, Zhang A, Sun H, Yan G. Potential drug targets on insomnia and intervention effects of Jujuboside A through metabolic pathway analysis as revealed by UPLC/ESI-SYNAPT-HDMS coupled with pattern recognition approach. J Proteomics. 2012;75(4):1411-27. 13. Childs RW, Carlsten M. Therapeutic approaches to enhance natural killer cell cytotoxicity against cancer: the force awakens. Nat Rev Drug Discov. 2015;14(7):487-98. 14. Zhang Y, Dong X, Le J, Wen J, Lin Z, Liu Y, Lou Z, Chai Y, Hong Z. A practical strategy for characterization of 9

MANUSCRIPT the metabolic profile of chiral drugsACCEPTED using combinatory liquid chromatography-mass spectrometric techniques: application to tetrahydropalmatine enantiomers and their metabolites in rat urine. J Pharm Biomed Anal. 2014;94:152-62. 15. Wong MY, So PK, Yao ZP. Direct analysis of traditional Chinese medicines by mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2016;1026:2-14. 16. Wu H, Guo J, Chen S, Liu X, Zhou Y, Zhang X, Xu X. Recent developments in qualitative and quantitative

RI PT

analysis of phytochemical constituents and their metabolites using liquid chromatography-mass spectrometry. J Pharm Biomed Anal. 2013;72:267-91.

17. Zhang A, Sun H, and Wang X. Mass spectrometry-driven drug discovery for development of herbal medicine.

SC

Mass Spec Rev. 2016;9999:1–14.

18. Sun H, Liu J, Zhang A, Zhang Y, Meng X, Han Y, Zhang Y, Wang X. Characterization of the multiple components of Acanthopanax Senticosus stem by ultra high performance liquid chromatography with quadrupole

M AN U

time-of-flight tandem mass spectrometry. J Sep Sci. 2016;39(3):496-502.

19. Wang H, Yan G, Zhang A, Li Y, Wang Y, Sun H, Wu X, Wang X. Rapid discovery and global characterization of chemical constituents and rats metabolites of Phellodendri amurensis cortex by ultra-performance liquid chromatography-electrospray ionization/quadrupole-time-of-flight

mass

spectrometry coupled

with

pattern

recognition approach. Analyst. 2013;138(11):3303-12.

TE D

20. Sun H, Liu C, Zhang A, Han Y, Yan G, Wang P, Wang X. Rapid discovery and global characterization of multiple constituents from Kai-Xin-San with an integrated MSE data acquisition mode strategy based on ultra-performance liquid chromatography coupled to electrospray ionization/quadrupole-time-of-flight mass

EP

spectrometry. Anal. Methods, 2015, 7, 279-286.

21. Huang H, Liu M, Chen P. Recent advances in ultra-high performance liquid chromatography for the analysis of

AC C

traditional Chinese medicine. Analytical letters, 2014, 47(11): 1835-1851. 22. Wang, X., Zhang, A., Sun, H., Han, Y., & Yan, G. Wang X, Zhang A, Sun H. Discovery and development of innovative drug from traditional medicine by integrated chinmedomics strategies in the post-genomic era. TrAC Trends in Analytical Chemistry, 201676: 86-94. 23. Liu C, Zhang A, Han Y, Wang X. Ultra-high performance liquid chromatography coupled with time-of-flight mass spectrometry screening and analysis of potential bioactive compounds from traditional chinese medicine Kai-Xin-San, using a multivariate data processing approach and the MetaboLynx tool. RSC Advances, 2015,5(1): 85-92. 24. Zhang A, Zou D, Yan G, Tan Y, Sun H, Wang X. Identification and characterization of the chemical constituents of Simiao Wan by ultra high performance liquid chromatography with mass spectrometry coupled to an automated multiple data processing method. J Sep Sci. 2014,37(14):1742-1747. 10

ACCEPTED MANUSCRIPT 25. Wang P, Yin QW, Zhang AH, Sun H, Wu XH, Wang XJ. Preliminary identification of the absorbed bioactive components and metabolites in rat plasma after oral administration of Shaoyao-Gancao decoction by ultra-performance liquid chromatography with electrospray ionization tandem mass spectrometry. Pharmacogn Mag. 2014,10(40):497-502. 26. Lu M, Cai Z. Advances of MALDI-TOF MS in the analysis of traditional Chinese medicines[M]//Applications of MALDI-TOF Spectroscopy. Springer Berlin Heidelberg, 2012: 143-164.

RI PT

27. Zhang, Z., Bo, T., Bai, Y., Ye, M., An, R., Cheng, F., Liu, H. Quadrupole time-of-flight mass spectrometry as a powerful tool for demystifying traditional chinese medicine. TrAC Trends in Analytical Chemistry, 2015, 72: 169-180.

multi-target metabolic network regulation. OMICS. 2015;19(3):186-95.

SC

28. Sun H, Wang H, Zhang A, Yan G, Zhang Y, An N, Wang X. Berberine ameliorates nonbacterial prostatitis via

29. Wang L, Tao W, Luo D, Hu Y, Bei W, Guo J. Potential synergistic effects of Chinese herbal prescription FTZ

M AN U

components detected in blood towards hepatic lipid-modulating targets. Complement Ther Med. 2014;22(5):887-93. 30. Chen YY, Li Q, Pan CS, Yan L, Fan JY, He K, Sun K, Liu YY, Chen QF, Bai Y, Wang CS, He B, Lv AP, Han JY. QiShenYiQi Pills, a compound in Chinese medicine, protects against pressure overload-induced cardiac hypertrophy through a multi-component and multi-target mode. Sci Rep. 2015;5:11802. 31. Zhang A, Sun H, Wang X. Potentiating therapeutic effects by enhancing synergism based on active constituents

TE D

from traditional medicine. Phytother Res. 2014;28(4):526-33. 32. Shen, C. Y., Jiang, J. G., Yang, L., Wang, D. W., & Zhu, W. (2017). Anti ageing active ingredients from herbs and nutraceuticals used in traditional Chinese medicine: pharmacological mechanisms and implications for drug

EP

discovery. British journal of pharmacology, 174(11), 1395-1425. 33. Zhang A, Sun H, Qiu S, Wang X. Advancing drug discovery and development from active constituents of

AC C

yinchenhao tang, a famous traditional chinese medicine formula. Evid Based Complement Alternat Med. 2013;2013:257909.

34. Wang X, Sun H, Zhang A, Jiao G, Sun W, Yuan Y. Pharmacokinetics screening for multi-components absorbed in the rat plasma after oral administration traditional Chinese medicine formula Yin-Chen-Hao-Tang by ultra performance liquid chromatography-electrospray ionization/quadrupole-time-of-flight mass spectrometry combined with pattern recognition methods. Analyst. 2011;136(23):5068-76. 35. Wang X, Zhang A, Wang P, Sun H, Wu G, Sun W, Lv H, Jiao G, Xu H, Yuan Y, Liu L, Zou D, Wu Z, Han Y, Yan G, Dong W, Wu F, Dong T, Yu Y, Zhang S, Wu X, Tong X, Meng X. Metabolomics coupled with proteomics advancing drug discovery toward more agile development of targeted combination therapies. Mol Cell Proteomics. 2013;12(5):1226-38.

11

ACCEPTED MANUSCRIPT 36. Chen H S, Qi S H, Shen J G. One-compound-multi-target: combination prospect of natural compounds with thrombolytic therapy in acute ischemic stroke. Current neuropharmacology, 2017, 15(1): 134-156. 37. Wang X, Wang Q, Zhang A, Zhang F, Zhang H, Sun H, Cao H, Zhang H. Metabolomics study of intervention effects of Wen-Xin-Formula using ultra high-performance liquid chromatography/mass spectrometry coupled with pattern recognition approach. J Pharm Biomed Anal. 2013;74:22-30. 38. Chu H, Zhang A, Han Y, Lu S, Kong L, Han J, Liu Z, Sun H, Wang X. Metabolomics approach to explore the

RI PT

effects of Kai-Xin-San on Alzheimer's disease using UPLC/ESI-Q-TOF mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2016;1015-1016:50-61.

39. Sun Q, Cao H, Zhou Y, Wang X, Jiang H, Gong L, Yang Y, Rong R. Qualitative and quantitative analysis of the

SC

chemical constituents in Mahuang-Fuzi-Xixin decoction based on high performance liquid chromatography combined with time-of-flight mass spectrometry and triple quadrupole mass spectrometers. Biomed Chromatogr. 2017. doi: 10.1002/bmc.3758

M AN U

40. Zhu H, Yin R, Han F, Guan J, Zhang X, Mao X, Zhao L, Li Q, Hou X, Bi K. Characterization of chemical constituents in Zhi-Zi-Da-Huang decoction by ultra high performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry. J Sep Sci. 2014;37(23):3489-96.

41. Yin Q, Wang P, Zhang A, Sun H, Wu X, Wang X. Ultra-performance LC-ESI/quadrupole-TOF MS for rapid analysis of chemical constituents of Shaoyao-Gancao decoction. J Sep Sci. 2013;36(7):1238-46.

TE D

42. Xing J, Zang M, Zhang H, Zhu M. The application of high-resolution mass spectrometry-based data-mining tools in tandem to metabolite profiling of a triple drug combination in humans. Anal Chim Acta. 2015;897:34-44. 43. Rzeppa S, Viet L. Analysis of sulfate metabolites of the doping agents oxandrolone and danazol using high

EP

performance liquid chromatography coupled to tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2016;1029-1030:1-9.

AC C

44. Wu F, Sun H, Wei W, Han Y, Wang P, Dong T, Yan G, Wang X. Rapid and global detection and characterization of the constituents in ShengMai San by ultra-performance liquid chromatography-high-definition mass spectrometry. J Sep Sci. 2011,34(22):3194-3199.

45. Zhang A, Liu Q, Zhao H, Zhou X, Sun H, Nan Y, Zou S, Ma CW, Wang X. Phenotypic characterization of nanshi oral liquid alters metabolic signatures during disease prevention. Sci Rep 2016,6:19333. 46. Yan GL, Zhang AH, Sun H, Han Y, Shi H, Zhou Y, Wang XJ. An effective method for determining the ingredients of Shuanghuanglian formula in blood samples using high-resolution LC-MS coupled with background subtraction and a multiple data processing approach. J Sep Sci. 2013;36(19):3191-9. 47. Liu P, Yang H, Long F, Hao HP, Xu X, Liu Y, Shi XW, Zhang DD, Zheng HC, Wen QY, Li WW, Ji H, Jiang XJ, Zhang BL, Qi LW, Li P. Bioactive equivalence of combinatorial components identified in screening of an herbal medicine. Pharm Res. 2014;31(7):1788-800. 12

ACCEPTED MANUSCRIPT 48. Wang X, Zhang A, Sun H, Wang P. Systems biology technologies enable personalized traditional Chinese medicine: a systematic review. Am J Chin Med. 2012;40(6):1109-22. 49. Ansermot N, Brawand-Amey M, Kottelat A, Eap CB. Fast quantification of ten psychotropic drugs and metabolites in human plasma by ultra-high performance liquid chromatography tandem mass spectrometry for therapeutic drug monitoring. J Chromatogr A. 2013;1292:160-72. 50. Shawky E. Multivariate analyses of NP-TLC chromatographic retention data for grouping of structurally-related

RI PT

plant secondary metabolites. J Chromatogr B Analyt Technol Biomed Life Sci. 2016;1029-1030:10-15

51. Xiao Y C, Liu L T, Bian J J. Identification of Multiple Constituents in Shuganjieyu Capsule and Rat Plasma after

Trap Mass Spectrometry. Acta Chromatographica, 2017: 1-8.

SC

Oral Administration by Ultra-Performance Liquid Chromatography Coupled with Electrospray Ionization and Ion

52. Ma S, Lv Q, Zhou H, et al. Identification of Traditional She Medicine Shi-Liang Tea Species and Closely Related Species Using the ITS2 Barcode. Applied Sciences, 2017, 7(3): 195.

M AN U

53. Tian JS, Peng GJ, Wu YF, Zhou JJ, Xiang H, Gao XX, Zhou YZ, Qin XM, Du GH. A GC-MS urinary quantitative metabolomics analysis in depressed patients treated with TCM formula of Xiaoyaosan. J Chromatogr B Analyt Technol Biomed Life Sci 2015, pii: S1570-0232(15)30352-4.

54. Yao H, Shi P, Huang X. A strategy for integrated pharmacokinetic study of cardiovascular herbal medicines based

13570-13583.

TE D

on chemiluminescence and HPLC-MS/MS assays: a case using Danshen injection. RSC Advances, 2017, 7(22):

55. Song W, Qiao X, Chen K, et al. Biosynthesis-Based Quantitative Analysis of 151 Secondary Metabolites of Licorice To Differentiate Medicinal Glycyrrhiza Species and Their Hybrids. Analytical Chemistry, 2017, 89(5):

EP

3146-3153.

56. Han Y, Zhang A, Sun H, Zhang Y, Meng X, Yan G, Liu L, Wang X. High-throughput ultra high performance

AC C

liquid chromatography combined with mass spectrometry approach for the rapid analysis and characterization of multiple constituents of the fruit of Acanthopanax senticosus (Rupr. et Maxim.) Harms. J Sep Sci. 2017;40(10):2178-2187.

57. Chen J, Zhou J, Wei S, Xie Z, Wen C, Xu G. Effect of a traditional Chinese medicine prescription Quzhuotongbi decoction on hyperuricemia model rats studied by using serum metabolomics based on gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2015, pii: S1570-0232(15)30250-6. 58. Wang L, Liu LF, Wang JY, Shi ZQ, Chang WQ, Chen ML, Yin YH, Jiang Y, Li HJ, Li P, Yao ZP, Xin GZ. A strategy to identify and quantify closely related adulterant herbal materials by mass spectrometry-based partial least squares regression. Anal Chim Acta. 2017;977:28-35. 59. Zhang QQ, Dong X, Liu XG, Gao W, Li P, Yang H. Rapid separation and identification of multiple constituents in Danhong Injection by ultra-high performance liquid chromatography coupled to electrospray ionization quadrupole 13

ACCEPTED time-of-flight tandem mass spectrometry. Chin J Nat Med.MANUSCRIPT 2016 Feb;14(2):147-60. 60. Dong P, Zhang L, Zhan L, Liu Y. Ultra high performance liquid chromatography with mass spectrometry for the rapid analysis and global characterization of multiple constituents from Zibu Piyin Recipe. J Sep Sci. 2016 Feb;39(3):595-602. 61. Zou D, Wang J, Zhang B, Xie S, Wang Q, Xu K, Lin R. Analysis of Chemical Constituents in Wuzi-Yanzong-Wan by UPLC-ESI-LTQ-Orbitrap-MS. Molecules. 2015;20(12):21373-404.

RI PT

62. Schänzer W, Thevis M. Human sports drug testing by mass spectrometry. Mass spectrometry reviews, 2017, 36(1): 16-46.

63. Yao Z H, Qin Z F, He L L. Identification, bioactivity evaluation and pharmacokinetics of multiple components in

SC

rat serum after oral administration of Xian-Ling-Gu-Bao capsule by ultra performance liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometry. Journal of Chromatography B, 2017, 1041: 104-112.

M AN U

64. Tang H, Zhang X, Luo S. Ultra high performance liquid chromatography with tandem mass spectrometry for rapid separation and identification of main constituents in Chinese herbal formula Xuan Hu Suo San. Natural Product Research, 2017: 1-5.

65. Cui Q, Pan Y, Yan X. A metabolic way to investigate related hurdles causing poor bioavailability in oral delivery of isoacteoside in rats employing ultrahigh

performance liquid chromatography/quadrupole time

of

flight

TE D

tandem mass spectrometry. Rapid Communications in Mass Spectrometry, 2017, 31(4): 371-380. 66. Sangthong S, Weerapreeyakul N, Lehtonen M, et al. High-accuracy mass spectrometry for identification of sulphur-containing bioactive constituents and flavonoids in extracts of Raphanus sativus var. caudatus Alef (Thai

EP

rat-tailed radish). Journal of Functional Foods, 2017, 31: 237-247. 67. Yan GL, Sun H, Zhang AH, Han Y, Wang P, Wu XH, Meng XC, Wang XJ. Progress of serum

AC C

pharmacochemistry of traditional Chinese medicine and further development of its theory and method. Zhongguo Zhong Yao Za Zhi. 2015;40(17):3406-12 68. Wang P, Yin QW, Zhang AH, Sun H, Wu XH, Wang XJ. Preliminary identification of the absorbed bioactive components and metabolites in rat plasma after oral administration of Shaoyao-Gancao decoction by ultra-performance liquid chromatography with electrospray ionization tandem mass spectrometry. Pharmacogn Mag. 2014;10(40):497-502. 69. Zhang AH, Sun H, Yan GL, Han Y, Wang XJ. Establishment of three-dimensional integrated "serum pharmacochemistry-pharmacokinetics (pharmacodynamics)-systems biology" for research of traditional Chinese medicine prescription and its application in Yinchenhao Tang. Zhongguo Zhong Yao Za Zhi. 2013;38(21):3786-9. 70. Zhang C, Lian R, Mahmoodurrahman M, Lai S, Zhao Z, Yu Y. Serum pharmacochemistry for tracking bioactive

14

MANUSCRIPT components by UPLC-Q-TOF-MS/MSACCEPTED combined chromatographic fingerprint for quality assessment of Sanziguben Granule. J Chromatogr B Analyt Technol Biomed Life Sci. 2016;1029-1030:128-36. 71. Lu SW, Zhang AH, Sun H, Yan GL, Han Y, Wu XH, Wang XJ. Ultra-performance liquid-chromatography with tandem mass spectrometry for rapid analysis of pharmacokinetics, biodistribution and excretion of schisandrin after oral administration of Shengmaisan. Biomed Chromatogr. 2013;27(12):1657-63. 72. Wang X, Zhang A, Zhou X, Liu Q, Nan Y, Guan Y, Kong L, Han Y, Sun H, Yan G. An integrated chinmedomics

RI PT

strategy for discovery of effective constituents from traditional herbal medicine. Sci Rep. 2016;6:18997.

73. Lv C, Chen L, Fu P. Simultaneous quantification of 11 active constituents in Shexiang Baoxin Pill by ultraperformance convergence chromatography combined with tandem mass spectrometry. Journal of

SC

Chromatography B, 2017, 1052: 135-141.

74. Zhang K, Yan G, Zhang A. Recent advances in pharmacokinetics approach for herbal medicine. RSC Advances,

M AN U

2017, 7(46): 28876-28888.

75. Du Y, He B, Li Q. Identification and analysis of chemical constituents and rat serum metabolites in Suan

Zao

Ren granule using ultra high performance liquid chromatography quadrupole time-of-flight mass spectrometry combined with multiple data processing approaches. Journal of Separation Science, 2017. 76. Tao Y, Du Y, Li W. Integrating UHPLC–MS/MS quantification and DAS analysis to investigate the effects of

TE D

wine-processing on the tissue distributions of bioactive constituents of herbs in rats: Exemplarily shown for Dipsacus asper. Journal of Chromatography B, 2017, 1055: 135-143.

77. He JL, Zhao JW, Ma ZC, Wang YG, Liang QD, Tan HL, Xiao CR, Tang XL, Gao Y. Serum Pharmacochemistry Analysis Using UPLC-Q-TOF/MS after Oral Administration to Rats of Shenfu Decoction. Evid Based Complement

EP

Alternat Med. 2015;2015:973930

78. Liu C, Zhang A, Yan GL, Shi H, Sun H, Han Y, Zhou Y, Wang X. High-throughput ultra high performance liquid

AC C

chromatography coupled to quadrupole time-of-flight mass spectrometry method for the rapid analysis and characterization of multiple constituents of radix polygalae. J Sep Sci. 2016. doi: 10.1002/jssc.20160062 79. Liu Q, Zhang A, Wang L, Yan G, Zhao H, Sun H, Zou S, Han J, Ma CW, Kong L, Zhou X, Nan Y, Wang X. High-throughput chinmedomics-based prediction of effective components and targets from herbal medicine AS1350. Sci Rep. 2016;6:38437. 80. Li XN, Zhang A, Sun H, Song Y, Zou D, Wang X. Rapid discovery of absorbed constituents and metabolites in rat plasma after the oral administration of Zi Shen Wan using high-throughput UHPLC-MS with a multivariate analysis approach. J Sep Sci. 2016. doi: 10.1002/jssc.201600812 81. Zhang Y, Zhang A, Zhang Y, Sun H, Meng X, Yan G, Wang X. Application of Ultra-performance Liquid Chromatography with Time-of-Flight Mass Spectrometry for the Rapid Analysis of Constituents and Metabolites

15

ACCEPTED MANUSCRIPT from the Extracts of Acanthopanax senticosus Harms Leaf. Pharmacogn Mag. 2016;12(46):145-52. 82. Wang Y, Li G, Zhou Y, Yin D, Tao C, Han L, Yue X, Pan Y, Yao Y, Peng D, Xu F. The difference between blood-associated and water-associated herbs of Danggui-Shaoyao San in theory of TCM, based on serum pharmacochemistry. Biomed Chromatogr. 2016;30(4):579-87. 82. An R, Li Y, Li M, Bai Y, Lu Y, Du Z. Plasma pharmacochemistry combined with pharmacokinetics and pattern recognition analysis to screen potentially bioactive components from Daming capsule using ultra high performance

RI PT

liquid chromatography with electrospray ionization quadrupole time-of-flight mass spectrometry. J Sep Sci. 201;38(9):1507-14.

83. Lim H, Gray P, Xie L, Poleksic A. Improved genome-scale multi-target virtual screening via a novel collaborative

SC

filtering approach to cold-start problem. Sci Rep. 2016;6:38860.

84. Ling Y, Li Z, Chen M, Sun Z, Fan M, Huang C. Analysis of multiple constituents in Cong-Ming-Tang, a Chinese herbal formula for the treatment of amnesia, by high-performance liquid chromatography with quadrupole

M AN U

time-of-flight mass spectrometry. Phytochem Anal. 2013;24(6):677-88.

85. Yang XX, Xu F, Wang D, Yang ZW, Tan HR, Shang MY, Wang X, Cai SQ. Development of a mitochondria-based centrifugal ultrafiltration/liquid chromatography/mass spectrometry method for screening mitochondria-targeted bioactive constituents from complex matrixes: Herbal medicines as a case study. J Chromatogr A. 2015;1413:33-46.

TE D

86. Zhang Y, Liu F, Zhang X, Xu T, Quan W, Wang H, Shi J, Dai Z, Wu B, Wu Q. Recognition and identification of active components from Radix Bupleuri using human neuroblastoma SH-SY5Y cells. Biomed Chromatogr. 2016;30(3):440-6.

EP

87. Wu Y, Peng Y, Song C, Li L, Ma H, Li D, Wang F, Yang J, Song S, Wu C. Separation and identification of multiple constituents in Xiao Chai Hu Decoction (Sho-saiko-to) by bioactivity-guided fractionation combined with

AC C

LC-ESI-QTOFMS/MS. Biomed Chromatogr. 2015;29(8):1146-66. 88. Qiao X, Ye M, Xiang C, Wang Q, Liu CF, Miao WJ, Guo DA.Analytical strategy to reveal the in vivo process of multi-component herbal medicine: a pharmacokinetic study of licorice using liquid chromatography coupled with triple quadrupole mass spectrometry. J Chromatogr A. 2012;1258:84-93 89. Wang Q, Cheng XL, Li H, Qin XY, Ge CY, Liu R, Qi LW, Qin MJ. Application of an efficient strategy for discovery and purification of bioactive compounds from Chinese herbal medicines, a case study on the Puerariae thomsonii Flos. J Pharm Biomed Anal. 2013;75:25-32. 90. Qiu S, Sun H, Zhang AH, Xu HY, Yan GL, Han Y, Wang XJ. Natural alkaloids: basic aspects, biological roles, and future perspectives. Chin J Nat Med. 2014;12(6):401-6. 91. Zhang AH, Sun H, Yan GL, Wang P, Han Y, Wang XJ. Chinmedomics: a new strategy for research of traditional Chinese medicine. Zhongguo Zhong Yao Za Zhi. 2015;40(4):569-76. 16

ACCEPTED MANUSCRIPT 92. Pan H, Yang W, Zhang Y, Yang M, Feng R, Wu W, Guo D. An integrated strategy for the systematic characterization and discovery of new indole alkaloids from Uncaria rhynchophylla by UHPLC/DAD/LTQOrbitrap-MS. Anal Bioanal Chem. 2015;407(20):6057-70. 93. Jin Y, Wu CS, Zhang JL, Li YF. A new strategy for the discovery of epimedium metabolites using high-performance liquid chromatography with high resolution mass spectrometry. Anal Chim Acta. 2013;768:111-7. 94. Ji S, Li Z, Song W, Wang Y, Liang W, Li K, Tang S, Wang Q, Qiao X, Zhou D, Yu S, Ye M. Bioactive

RI PT

Constituents of Glycyrrhiza uralensis (Licorice): Discovery of the Effective Components of a Traditional Herbal Medicine. J Nat Prod. 2016;79(2):281-92.

95. Jiang Z, Wang Y, Zhu Y, Zhang L, Chai X, Jiang M, Shan L. Dose-dependent targeted knockout methodology

SC

combined with deep structure elucidation strategies for Chinese licorice chemical profiling. J Pharm Biomed Anal. 2015;115:130-7.

96. Zhou XH, Zhang AH, Wang L, Tan YL, Guan Y, Han Y, Sun H, Wang XJ. Novel chinmedomics strategy for

M AN U

discovering effective constituents from ShenQiWan acting on ShenYangXu syndrome. Chin J Nat Med.

AC C

EP

TE D

2016;14(8):561-81.

17

TE D

M AN U

SC

RI PT

ACCEPTED MANUSCRIPT

Fig. 1 Schematic of the proposed integrated chinmedomics strategy for the discovery of novel bioactive molecules

AC C

EP

from herbal medicines.

18

ACCEPTED MANUSCRIPT Highlights 1. Herbal preparation has been recognized as an important reservoir of bioactive lead compounds. 2. Mass spectrometry has led to discovery of many active constituents from herbal preparation. 3. Exploration of candidate drug is greatly promoted by high-throughput MS platform.

AC C

EP

TE D

M AN U

SC

RI PT

4. Evolving MS screening approach enables a revolution for drug discovery of herbal medicine.

1